companydata.dkcompanydata.dk

RhomeoX ApS: Financial statements 2024

CVR: 43458078

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

RhomeoX ApS (CVR 43458078) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -14,150 and a net result of DKK -14,106. Equity in the 2024 report amounted to DKK 12,764. The solvency ratio was 59.3%.

Gross Profit
DKK -14,150
Profit/Loss
DKK -14,106
Equity
DKK 12,764
Total Assets
DKK 21,514

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

RhomeoX ApS publishes interim reportJun 28, 2024

RhomeoX ApS has published its interim report for the period August 18, 2022 – December 31, 2023.

About RhomeoX ApS

RhomeoX ApS is a Danish company of the type Anpartsselskab based in Odense M, founded in 2022. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Jens Christian Jensenius. The company is owned by KLITLUND ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -16,025 and a net result of DKK -9,396 compared with DKK -14,106 the year before. Equity in the 2025 report amounted to DKK 3,368.

Source: annual report 2025, Danish Business Authority

Other financial years